tirzepatide and nash for the treatment of metabolic dysfunction-associated steatohepatitis with liver fibrosis: results of the SYNERGY-NASH phase 2 trial Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis

7.4 IGF-1 induces cell differentiation Current regenerative research has focused on the studies of growth factor supplementation that can induce stem cells into tenogenic lineage for an alternative cell source to replenish functional tendon cells at the injured site ( in vitro culture with significant upregulation of tenocytic markers (SCX, collagen type III, and decorin) ( in vivo data are available regarding the efficacy of exogenously delivery of IGF-1 in combination with stem cells to treat tendon injury

10.1073/pnas.0237106100 Proc

Park YY, Lee SS, Lim JY, Kim SC, Kim SB, Sohn BH, Chu IS, Oh SC, Park ES, Jeong W, Kim SS, Kopetz S , Lee JS

Serum adiponectin level in osteoporotic postmenopausal women with type 2 diabetes mellitus